Filtros de búsqueda

Lista de obras de Laura C. Coates

2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

scientific article published on 30 November 2018

2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

scholarly article

A discrete choice experiment to explore patients' willingness to risk disease relapse from treatment withdrawal in psoriatic arthritis ⬇️

artículo científico publicado en 2016

A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F))

A new era for collaboration?

artículo científico publicado en 2017

Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity

article

An educational leaflet improves response to invitation for screening for arthritis in patients with psoriasis in primary care, but only in practices in the most deprived areas ⬇️

artículo científico publicado en 2016

Anti-TNF Therapy in Ankylosing Spondylitis: Insights for the Clinician

artículo científico publicado en 2010

Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-analysis

artículo científico publicado en 2020

Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set.

artículo científico publicado en 2011

Appraisal of candidate instruments for assessment of the physical function domain in patients with psoriatic arthritis

scientific article published on 1 February 2020

Assessing Disease Activity in Psoriatic Arthritis: A Literature Review

artículo científico publicado en 2018

Assessment of the many faces of PsA: single and composite measures in PsA clinical trials

artículo científico publicado en 2020

Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis ⬇️

artículo científico publicado en 2018

BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management

artículo científico publicado en 2020

Best-practice Indicators in Psoriatic Disease Care

artículo científico publicado en 2019

Can biologic therapies be withdrawn or tapered in psoriatic arthritis?

artículo científico publicado en 2013

Classification and Outcome Measures for Psoriatic Arthritis

article

Classification and categorisation of psoriatic arthritis

artículo científico publicado en 2008

Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis

Clinical management of psoriatic arthritis

artículo científico publicado en 2018

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review

artículo científico publicado en 2020

Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review

artículo científico publicado en 2008

Comment on: Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2010

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries

artículo científico publicado en 2018

Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial

artículo científico publicado en 2019

Comparing the patient reported physical function outcome measures in a real-life international cohort of patients with psoriatic arthritis

scientific article published on 21 January 2020

Comparing the visual analogue scale (VAS) and the numerical rating scale (NRS) in patient reported outcomes in psoriatic arthritis

artículo científico publicado en 2020

Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value

artículo científico publicado en 2018

Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study

artículo científico publicado en 2020

Comparison of screening questionnaires to identify psoriatic arthritis in a primary-care population: a cross-sectional study ⬇️

artículo científico publicado en 2016

Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study).

artículo científico publicado en 2013

Composite measures in psoriatic arthritis: GRAPPA 2008.

artículo científico publicado en 2010

Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort

artículo científico publicado en 2012

Concurrent Oral 6 - Spondylarthropathies [OP40-OP47]: OP40. Association of IL23R and IL12B Polymorphisms with Psoriatic Arthritis

Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis

artículo científico publicado en 2011

Considerations for the definition of remission criteria in psoriatic arthritis

artículo científico publicado en 2017

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting

scientific article published on 1 June 2018

Current concepts and unmet needs in psoriatic arthritis

artículo científico publicado en 2017

Defining Low Disease Activity States in Psoriatic Arthritis using Novel Composite Disease Instruments

artículo científico publicado en 2015

Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group

artículo científico publicado en 2017

Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment

artículo científico publicado en 2010

Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA).

artículo científico publicado en 2018

Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association with Gender in 458 Patients from 14 Countries

artículo científico publicado en 2019

Determinants of sleep impairment in psoriatic arthritis: an observational study with 396 patients from 14 countries

scientific article published on 10 April 2020

Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools

artículo científico publicado en 2014

Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.

artículo científico

Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group

artículo científico publicado en 2011

Development of a preliminary composite disease activity index in psoriatic arthritis

artículo científico publicado en 2010

Disease measurement--enthesitis, skin, nails, spine and dactylitis

artículo científico publicado en 2010

Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease ⬇️

scientific article published on 29 October 2018

Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis

artículo científico publicado en 2010

Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review

artículo científico publicado en 2014

Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients

artículo científico publicado en 2019

Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)

scientific article published on 18 October 2019

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

artículo científico publicado en 2015

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial ⬇️

artículo científico publicado en 2018

Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies

Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report

scientific article published on 15 February 2019

Erratum to “New sources and instrumentation for neutrons in biology” [Chem. Phys. 345 (2008) 133–151]

scholarly article published in Chemical Physics

Essentials in Rheumatology: Disease Management * I29. Recognition and Management of the Auto-Inflammatory Diseases

Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris

artículo científico publicado en 2011

Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort

artículo científico publicado en 2010

GRAPPA 2015 Research and Education Project Reports

artículo científico publicado en 2016

GRAPPA 2016 Project Report

artículo científico publicado en 2017

GRAPPA 2017 Project Report

artículo científico publicado en 2018

GRAPPA 2018 Project Report

artículo científico publicado en 2019

GRAPPA 2019 Project Report

artículo científico publicado en 2020

GRAPPA Trainees Symposium 2009: a report from the GRAPPA 2009 annual meeting

artículo científico publicado en 2011

GRAPPA Treatment Recommendations: Updates and Methods

artículo científico publicado en 2020

GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual Meeting

artículo científico publicado en 2014

GRAPPA-OMERACT consensus-based recommendations and research agenda for use of composite measures and treatment targets in PsA. ⬇️

artículo científico publicado en 2017

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies

artículo científico publicado en 2017

Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force

artículo científico publicado en 2022

Gender equity in academic rheumatology: is there a gender gap at European rheumatology conferences?

artículo científico publicado en 2022

Gender equity in clinical practice, research and training: Where do we stand in rheumatology?

scientific article published on 17 June 2019

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

artículo científico publicado en 2016

How routine use of a treat to target approach in PsA might impact on clinical decision making

artículo científico publicado en 2018

Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort

artículo científico publicado en 2017

Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008.

artículo científico publicado en 2010

Improving recognition of psoriatic arthritis

artículo científico publicado en 2009

Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients

artículo científico publicado en 2017

Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study

artículo científico publicado en 2017

Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting

artículo científico publicado en 2013

Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity

scholarly article

Interleukin-17 inhibition in psoriatic arthritis

artículo científico publicado en 2015

International Treatment Recommendations Update: A Report from the GRAPPA 2016 Annual Meeting

artículo científico publicado en 2017

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

artículo científico publicado en 2016

Is there subclinical enthesitis in early psoriatic arthritis? A clinical comparison with power doppler ultrasound

artículo científico publicado en 2012

Is there subclinical synovitis in early psoriatic arthritis? A clinical comparison with gray-scale and power Doppler ultrasound

artículo científico publicado en 2014

Ixekizumab efficacy and safety with and without concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) in biologic DMARD (bDMARD)-naïve patients with active psoriatic arthritis (PsA): results from SPIRIT-P1.

artículo científico publicado en 2017

L.C. Coates and P.S. Helliwell reply

artículo científico publicado en 2016

Let's Talk about Inclusion: A Report on Patient Research Partner Involvement in the GRAPPA 2015 Annual Meeting

artículo científico publicado en 2016

Linear pitting and splinter haemorrhages are more commonly seen in the nails of patients with established psoriasis in comparison to psoriatic arthritis

artículo científico publicado en 2011

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial

artículo científico publicado en 2020

MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis

artículo científico

Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations

artículo científico publicado en 2016

Measurement properties of the minimal disease activity criteria for psoriatic arthritis

artículo científico publicado en 2019

Measuring Outcomes in Psoriatic Arthritis

artículo científico publicado en 2020

Methotrexate Efficacy in the Tight Control in Psoriatic Arthritis Study ⬇️

artículo científico publicado en 2015

Methotrexate in Psoriasis and Psoriatic Arthritis

artículo científico publicado en 2020

Minimal Disease Activity among Active Psoriatic Arthritis Patients Treated with Secukinumab: 2-year Results from the FUTURE 2 Study

artículo científico publicado en 2018

Mixed methods study of clinicians' perspectives on barriers to implementation of treat to target in psoriatic arthritis

scientific article published on 18 May 2020

More than meets the eye?

artículo científico publicado en 2016

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis. ⬇️

artículo científico publicado en 2017

New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation

artículo científico publicado en 2016

Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?

Optimisation of rheumatology indices: dactylitis and enthesitis in psoriatic arthritis

artículo científico publicado en 2014

Outcome Measures in Psoriatic Arthritis

artículo científico publicado en 2015

Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps

artículo científico publicado en 2020

Patient education and screening for psoriatic arthritis is key in the care of patients with psoriasis, whichever method is chosen

artículo científico publicado en 2017

Patient involvement in outcome measures for psoriatic arthritis

artículo científico

Performance and Predictors of Minimal Disease Activity Response in Peripheral Spondyloarthritis Patients Treated With Adalimumab

scientific article published on 16 September 2020

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis

scientific article published on 30 August 2020

Personalized medicine - a new reality in psoriatic arthritis?

artículo científico publicado en 2018

Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial

artículo científico publicado en 2017

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies

scientific article published on 19 June 2018

Prevalence of psoriatic arthritis patients achieving minimal disease activity in real-life studies and randomized clinical trials: systematic review with metanalysis

scientific article published on 1 October 2019

Proceedings of the GRAPPA 2016 Retreat

artículo científico publicado en 2017

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials

article

Psoriasis flare with corticosteroid use in psoriatic arthritis ⬇️

artículo científico publicado en 2015

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same? ⬇️

artículo científico publicado en 2016

Psoriatic arthritis: lessons from imaging studies and implications for therapy ⬇️

artículo científico publicado en 2016

Psoriatic arthritis: state of the art review

artículo científico publicado en 2017

Qualifying unmet needs and improving standards of care in psoriatic arthritis

artículo científico publicado en 2014

Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis-Correction

artículo científico publicado en 2021

Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo-Controlled Study

artículo científico publicado en 2015

Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis

artículo científico publicado en 2008

Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease

artículo científico publicado en 2013

Relationship Between Fatigue and Inflammation, Disease Duration, and Chronic Pain in Psoriatic Arthritis: An Observational DANBIO Registry Study

scientific article published on 15 July 2019

Remission in psoriatic arthritis-where are we now? ⬇️

artículo científico publicado en 2017

Reply to comment on: Clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial.

artículo científico publicado en 2017

Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting

scientific article published on 1 June 2018

Response to: 'To DAPSA or not to DAPSA? That is not the question' by Schoels et al

artículo científico publicado en 2018

Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire

artículo científico publicado en 2020

Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study

artículo científico publicado en 2020

Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies

artículo científico publicado en 2019

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial

scientific article published on 17 December 2020

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study

article

Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis

artículo científico publicado en 2012

Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years

artículo científico publicado en 2008

Should Methotrexate Have Any Place in the Treatment of Psoriatic Arthritis?

scientific article published on 30 May 2019

Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future

artículo científico publicado en 2011

Summary of the International Federation of Psoriasis Associations (IFPA) meeting: a report from the GRAPPA 2009 annual meeting

artículo científico publicado en 2011

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients

artículo científico publicado en 2019

Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience

artículo científico publicado en 2007

Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA.

artículo científico publicado en 2014

Tackling Patient Centricity: A Report from the GRAPPA 2016 Annual Meeting

artículo científico publicado en 2017

Tapering and Discontinuation of Biologics in Patients with Psoriatic Arthritis with Low Disease Activity

artículo científico publicado en 2018

Testing an OMERACT MRI Scoring System for Peripheral Psoriatic Arthritis in Cross-sectional and Longitudinal Settings

article

The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

artículo científico publicado en 2013

The Benefits and Challenges of Setting Up a Longitudinal Psoriatic Arthritis Database

scientific article published on 1 June 2018

The Changing Face of Clinical Trials in Psoriatic Arthritis

artículo científico publicado en 2017

The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes ⬇️

artículo científico publicado en 2017

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set

artículo científico publicado en 2019

The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates

artículo científico publicado en 2020

The OMERACT MRI inflammatory arthritis group: advances and future research priorities

artículo científico publicado en 2009

The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) is reliable and sensitive to change: results from an OMERACT workshop

artículo científico publicado en 2011

The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands

scientific article published on August 2009

The Role of Ultrasound in Psoriatic Arthritis - Do We Need a Score?

scientific article published on 01 April 2019

The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis ⬇️

artículo científico publicado en 2013

The cost-effectiveness of tight control of inflammation in early psoriatic arthritis: Economic analysis of the TICOPA trial ⬇️

artículo científico

The definition of remission in psoriatic arthritis: can this be accurate without assessment of multiple domains?

artículo científico publicado en 2015

The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial ⬇️

artículo científico publicado en 2017

The ethics of ‘Trials within Cohorts’ (TwiCs): 2nd international symposium: London, UK. 7-8 November 2016

artículo científico publicado en 2017

The involvement of the spine in psoriatic arthritis

artículo científico

The phenotype of axial spondyloarthritis: is it dependent on HLA-B27 status?

artículo científico publicado en 2020

The second World Psoriasis and Psoriatic Arthritis Conference 2009: 'psoriasis--skin and beyond'.

artículo científico publicado en 2010

Therapy strategies in psoriatic arthritis

artículo científico

Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need use CRP?' by Gonçalves et al

scientific article published on 22 July 2019

Treat to target in psoriatic arthritis-evidence, target, research agenda

artículo científico

Treat-to-target in PsA: methods and necessity

scientific article published on 01 February 2020

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force ⬇️

artículo científico publicado en 2017

Treating to target in psoriatic arthritis

artículo científico publicado en 2015

Treating to target in psoriatic arthritis: how to implement in clinical practice

artículo científico

Treatment guidelines in psoriatic arthritis

scientific article published on 01 March 2020

Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope

artículo científico publicado en 2020

Treatment to Target in Psoriatic Arthritis with Apremilast: Probability of Achieving Targets and Comprehensive Control of Disease Manifestations

artículo científico publicado en 2020

Update on research and future directions of the OMERACT MRI inflammatory arthritis group

artículo científico publicado en 2011

Update on the OMERACT magnetic resonance imaging task force: research and future directions

artículo científico publicado en 2013

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

artículo científico publicado en 2017

Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data

artículo científico publicado en 2010

Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab

artículo científico publicado en 2018

Value of RAPID3 in patients with PsA: results from the TICOPA and LOPAS II databases ⬇️

artículo científico publicado en 2017

Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis

artículo científico publicado en 2010

What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis?

scholarly article by Laura C. Coates et al published 15 September 2018 in The Journal of Rheumatology

Improving the outcome of psoriatic arthritis ⬇️

tesis doctoral

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda